Get the Stockscreener App
2.90
1.40%
0.04
Sensus Healthcare Inc stock is traded at $2.90, with a volume of 17,055.
It is up +1.40% in the last 24 hours and down -3.97% over the past month.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
See More
Previous Close:
$2.86
Open:
$2.85
24h Volume:
17,055
Relative Volume:
0.44
Market Cap:
$47.74M
Revenue:
$22.53M
Net Income/Loss:
$-7.77M
P/E Ratio:
-6.1078
EPS:
-0.4748
Net Cash Flow:
$-740.00K
1W Performance:
-6.15%
1M Performance:
-3.97%
6M Performance:
-24.28%
1Y Performance:
-13.43%
1-Day Range:
$2.85
$2.93
1-Week Range:
$2.80
$3.34
52-Week Range:
$2.66
$5.49
Sensus Healthcare Inc Stock (SRTS) Company Profile
Name
Sensus Healthcare Inc
Sector
Industry
Phone
561-922-5808
Address
851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL
Compare SRTS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRTS
Sensus Healthcare Inc
|
2.90 | 47.08M | 22.53M | -7.77M | -740.00K | -0.4748 |
ABT
Abbott Laboratories
|
109.67 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
331.50 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.58 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.45 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.68 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Initiated | Alliance Global Partners | Buy |
| Jan-31-25 | Initiated | Lake Street | Buy |
| Nov-15-24 | Reiterated | Maxim Group | Buy |
| Feb-26-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Dec-16-20 | Downgrade | Northland Capital | Outperform → Market Perform |
| Aug-10-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Feb-14-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Nov-07-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jan-29-19 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-26-18 | Initiated | B. Riley FBR | Buy |
| Nov-03-17 | Reiterated | Maxim Group | Buy |
| Jun-06-17 | Initiated | Maxim Group | Buy |
| Aug-08-16 | Initiated | Northland Capital | Outperform |
View All
Sensus Healthcare Inc Stock (SRTS) Latest News
Q2 2026 Sensus Healthcare Inc Earnings Call Transcript - GuruFocus
SRTS Maintained by Lake Street -- Price Target Lowered to $4.00 - GuruFocus
Sensus Healthcare, Inc. Q2 2026: Revenue $2.29M, EPS $(0.53) — 10-Q Summary - TradingView
Sensus Healthcare, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Applied Materials, Globant And 3 Stocks To Watch Heading Into Friday - Benzinga
SRTS Looks 15.9% Overvalued on GF Value™ - GuruFocus
Sensus Healthcare Q2 Earnings Call Highlights - MarketBeat
Sensus Healthcare Q2 Adjusted Ebitda USD -3.0 - Moomoo
Sensus Healthcare Q2 EPS $(0.53) misses estimate; sales fall 69% - scanx.trade
Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Expectations By $0.41 EPS - MarketBeat
Earnings call transcript: Sensus Healthcare posts Q2 2026 miss, shares fall after hours - Investing.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Sensus Healthcare Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Full Transcript: Sensus Healthcare Q2 2026 Earnings Call - Benzinga
SENSUS HEALTHCARE ($SRTS) Releases Q2 2026 Earnings - Quiver Quantitative
Sensus Healthcare Inc (SRTS) Faces Challenges in Q2 Earnings: Re - GuruFocus
Sensus Healthcare Q2 revenue misses estimates as unit sales fall - TradingView
SRTS: Q2 2026 revenue dropped 68.5% year-over-year, but commercial momentum and pipeline remain strong - TradingView
CMS Proposes 26% Increase in Sensus Hospital Delivery Code - Stock Titan
Sensus Healthcare Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
Sensus Healthcare Inc (SRTS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sensus Healthcare Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Earnings Preview: SRTS to Report Financial Results Post-market on August 13 - Moomoo
Sensus Healthcare Inc (SRTS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SRTS Q2'26 Earnings: revenue estimate is 4.60M USD - TradingView
Axogen, Inc. (AXGN) options chain - au.finance.yahoo.com
Sensus Healthcare (SRTS) Edges Higher by 1.71% as Stock Approaches Key $3.12 ResistanceRating Change - dars.gov.et
Sensus Healthcare, Inc. Revenue Breakdown – NASDAQ:SRTS - TradingView
Sensus Healthcare Q2 Results: Company to report earnings on August 13 - scanx.trade
SRTS Q1 2026 Earnings: Wider-than-Expected Loss as Cost Pressures PersistCEO Earnings Statement - dars.gov.et
Sensus Healthcare Q2 update will stream live Aug. 13 at 4:30 p.m. - Stock Titan
SRTS|Sensus Healthcare Inc|Price:3.070|Chg%:+0.090 - TradingKey
Sensus Healthcare Inc (SRTS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SRTS|Sensus Healthcare Inc|Price:3.055|Chg%:-0.015 - TradingKey
Sensus Healthcare Inc (SRTS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sensus Healthcare Inc (SRTS) Cash Flow - TradingKey
Sensus Healthcare Inc (SRTS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sensus Healthcare, Inc. Revenue Breakdown – LS:A2JPJ1 - TradingView
SRTS|Sensus Healthcare Inc|Price:3.150|Chg%:+0.020 - TradingKey
TradingKey - TradingKey
Sensus Healthcare, Inc. Revenue Breakdown – TRADEGATE:5TX - TradingView
Sensus Healthcare (SRTS) Gains 3% as Stock Tests Resistance Near $3.18Relative Volume - dars.gov.et
Sensus Healthcare Inc (SRTS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sensus Healthcare (SRTS) Holds Steady at $3.08 as Support and Resistance Levels TightenGEX Level - dars.gov.et
Sensus Healthcare (SRTS) Q4 2025 earnings summary - Quartr
Lake Street Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Maintains Target Price $4.5 - Moomoo
Earnings call transcript: Sensus Healthcare misses Q1 2026 forecasts - Investing.com
Sensus Healthcare (SRTS) Holds Steady at $3.02 Amid Key Support and Resistance LevelsWyckoff Distribution - dars.gov.et
Tecsys Inc (TCYSF) Q4 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... - Yahoo Finance
SRTS Q1 2026 Earnings: EPS Misses Estimates, Stock Rises 3.05%Earnings Growth Forecast - dars.gov.et
Sensus Healthcare, Inc. (SRTS) Investigation: Bronstein, Gewirtz - The National Law Review
Sensus Healthcare Inc Stock (SRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sensus Healthcare Inc Stock (SRTS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sachetta Eric | Director |
Feb 24 '26 |
Buy |
3.81 |
2,000 |
7,620 |
142,113 |
| Sachetta Eric | Director |
Nov 21 '25 |
Buy |
3.93 |
7,000 |
27,510 |
140,113 |
| Sachetta Eric | Director |
Nov 13 '25 |
Buy |
4.50 |
2,500 |
11,250 |
133,113 |
| Sardano Joseph C | CHIEF EXECUTIVE OFFICER |
Nov 18 '25 |
Buy |
4.03 |
25,000 |
100,750 |
1,200,293 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 18 '25 |
Buy |
3.80 |
1,000 |
3,800 |
118,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 11 '25 |
Buy |
4.26 |
1,000 |
4,260 |
117,839 |
2.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):